Can you identify the latest developments related to the treatment of blood cancers? Test your knowledge.

Answer: A. Has been approved by the FDA for selected applications in treating blood cancer

ANSWER: C. Side effects tend to be more severe than with standard therapy

ANSWER: C. A patient is diagnosed with non-Hodgkin lymphoma: 

66,769 people diagnosed with non-Hodgkin lymphoma in 2104 --the most recent year for which numbers are available-versus 8,581 with Hodgkin lymphoma. Deaths: 20,387 from non-Hodgkin lymphoma; 1,077 from Hodgkin lymphoma).

Sources: Unless otherwise noted, information was taken from public domains such as the National Cancer Institute and the CDC.